Completed Clinical Trials

Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma

By April 24, 2017 No Comments

Condition

Malignant Pleural Mesothelioma

Estimated Enrollment: 20

Age Group: 20 Years to 75 Years   (Adult, Senior)

Gender: All

Study Type: Interventional

Study Design Allocation: Allocation: Non-Randomized|Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment

Study ID Numbers: 10512|H3E-JE-ME02

Study First Received: October 10, 2006

Last Updated: April 10, 2007

Estimated Primary Completion Date: null

 

Primary Outcome Measures:

To investigate safety profile when administered pemetrexed combined with cisplatin in malignant pleural mesothelioma patients|To investigate efficacy when administered pemetrexed combined with cisplatin in malignant pleural mesothelioma patients

Sponsors and Collaborators:

Eli Lilly and Company

Website Link: https://ClinicalTrials.gov/show/NCT00386815

Leave a Reply

Call Now ButtonCall Now